InterAxInterAx
InterAx

InterAx

AI-powered drug discovery platform for GPCR targets, accelerating development and reducing risk.

Website
2016Active15
Rate
Advertise here

About

InterAx Biotech develops novel therapies by translating complex biology into breakthrough medicines using its Deep Signal™ platform. This platform integrates mathematical modeling, experimental methods, and machine learning to decipher cell signaling language, enabling the design of highly efficacious small molecule drug candidates targeting GPCRs. InterAx serves to generate high-efficacy leads and improve drug profiles by understanding disease impact before pre-clinical trials.

Technology stack

detected 2026-06-15
Est. monthly stack spend~$250/mo
EmailMicrosoft 365
Hosting
OVHcloud
Stack
jQueryWordPress
Analytics
Google Analytics 4
SEO
Rank Math
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does InterAx do?

InterAx Biotech develops novel therapies by translating complex biology into breakthrough medicines using its Deep Signal™ platform. This platform integrates mathematical modeling, experimental methods, and machine learning to decipher cell signaling language, enabling the design of highly efficacious small molecule drug candidates targeting GPCRs. InterAx serves to generate high-efficacy leads and improve drug profiles by understanding disease impact before pre-clinical trials.

How much funding has InterAx raised?

InterAx has raised a total of $3M in funding. The most recent round on record is Funding Round.

Where is InterAx headquartered?

InterAx is headquartered in Schlieren, Switzerland.

When was InterAx founded?

InterAx was founded in 2016.

What industry does InterAx operate in?

InterAx operates in Biotech, Drug Discovery, AI, Computational Pharmacology, GPCR, Platform.

How many employees does InterAx have?

InterAx has approximately 15 people on record.